Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Aaron W. Trammell"'
Autor:
Lauren M. Crossman, Priyanka Rajaram, Charles Michael Hart, Maria A. Pernetz, Anurag Sahu, Maan Jokhadar, Wendy M. Book, Micah R. Fisher, Aaron W. Trammell
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 1, Pp n/a-n/a (2023)
Abstract Evaluation for right ventricular (RV) dysfunction is an important part of risk assessment in care of patients with pulmonary hypertension (PH) as it is associated with morbidity and mortality. Echocardiography provides a widely available and
Externí odkaz:
https://doaj.org/article/9e0008b4f428484fb378e93b1743dcaa
Autor:
Fadi Rabih, Rhiannon L. Holden, Payaswini Vasanth, Stephen O. Pastan, Micah R. Fisher, Aaron W. Trammell
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 1, Pp n/a-n/a (2022)
Abstract Pulmonary hypertension affects about one in four patients with advanced chronic kidney disease and significantly increases the risk of death. Kidney transplantation is the recommended management option for patients with progressive or end‐
Externí odkaz:
https://doaj.org/article/3ba9235443244782a12014f44ec2493b
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Pulmonary hypertension (PH) occurs when the pulmonary vasculature is itself diseased or becomes affected secondarily by comorbid conditions, commonly left heart or lung disease. The high prevalence of chronic cardiopulmonary conditions among patients
Externí odkaz:
https://doaj.org/article/750b734cade54e049285d3c86f2c4be5
Autor:
Xiangqin Cui, Amit J. Shah, Lawrence S. Phillips, David Benkeser, C. Michael Hart, Anna R. Hemnes, Aaron W. Trammell, Julia W. Gallini
Publikováno v:
Chest. 161:803-806
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::974f2f3b01d251acadd4ee72da709c4a
https://doi.org/10.1016/j.chest.2021.09.005
https://doi.org/10.1016/j.chest.2021.09.005
Publikováno v:
Chest. 162:A2369-A2370
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaa6e6a9e9f992c4d25cba1f401f53d9
https://doi.org/10.1016/j.chest.2022.08.1949
https://doi.org/10.1016/j.chest.2022.08.1949
Autor:
Fadi Rabih, Rhiannon L. Holden, Payaswini Vasanth, Stephen O. Pastan, Micah R. Fisher, Aaron W. Trammell
Publikováno v:
Pulmonary circulation. 12(1)
Pulmonary hypertension affects about one in four patients with advanced chronic kidney disease and significantly increases the risk of death. Kidney transplantation is the recommended management option for patients with progressive or end-stage kidne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910e13496d2c7d27b20fc211dca3a02b
https://pubmed.ncbi.nlm.nih.gov/35506090
https://pubmed.ncbi.nlm.nih.gov/35506090
Autor:
Aaron W. Trammell, C.M. Hart
Publikováno v:
B97. WHAT'S NEW IN CLINICAL RESEARCH IN PULMONARY HYPERTENSION: LESSONS FROM THE BEST ABSTRACTS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::826beb433041bec6cc20d6cd1809c1ee
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4241
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4241
Autor:
Amit J. Shah, C.M. Hart, Lawrence S. Phillips, Anna R. Hemnes, Aaron W. Trammell, Victor Tseng
Publikováno v:
Am J Cardiol
Pulmonary hypertension (PH) is a complex condition that arises due to pulmonary vascular disease, heart disease, lung disease, chronic thromboembolism, or several rare causes. Regardless of underlying cause, PH increases mortality, yet there are no d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2efb6b8f81f1df3f6680a288051c145b
https://pubmed.ncbi.nlm.nih.gov/32919617
https://pubmed.ncbi.nlm.nih.gov/32919617
Autor:
Aaron W. Trammell, C. Michael Hart
Publikováno v:
Chest
BACKGROUND: The renin-angiotensin-aldosterone system (RAAS) contributes to pulmonary hypertension (PH) pathogenesis. Although animal data suggest that RAAS inhibition attenuates PH, it is unknown if RAAS inhibition is beneficial in PH patients. RESEA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b3d3d8aac242079277281af23eb262
https://doi.org/10.1016/j.chest.2020.10.065
https://doi.org/10.1016/j.chest.2020.10.065
Autor:
James West, Anna R. Hemnes, Megha Talati, John H. Newman, Thomas R. Blackwell, Niki L Fortune, Joshua P. Fessel, Kevin D. Niswender, Aaron W. Trammell
Publikováno v:
Pulmonary Circulation
Pulmonary arterial hypertension (PAH) is associated with metabolic derangements including insulin resistance, although their effects on the cardiopulmonary disease are unclear. We hypothesized that insulin resistance promotes pulmonary hypertension (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4bf3df35ab3e7fc0fda0644a4cacee2
http://europepmc.org/articles/PMC5841889
http://europepmc.org/articles/PMC5841889